华润医药(03320)：华润双鹤前三季度净利润13.88亿元，同比下降1.7%

Core Insights - China Resources Pharmaceutical (华润医药) reported a total revenue of 8.283 billion RMB for the nine months ending September 30, 2025, representing a year-on-year decline of 3.1% [1] - The net profit for the same period was 1.388 billion RMB, which is a decrease of 1.7% compared to the previous year [1] Financial Performance - Total revenue: 8.283 billion RMB, down 3.1% year-on-year [1] - Net profit: 1.388 billion RMB, down 1.7% year-on-year [1]